Quantitative determination of 2’-Hydroxy-3’,4’-methylenedioxy-3,4,5-trimethoxychalcone (HMTC) in rat plasma by HPLC-MS/MS and its application to a pharmacokinetic study
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
2’-Hydroxy-3’,4’-methylenedioxy-3,4,5-trimethoxychalcone (HMTC) is a newly synthesized chalcone that affects proliferation, cytotoxic potential and apoptosis in human leukemia cells. However, no validated determination method has been described so far for HMTC in biological samples. Thus, we developed a liquid chromatographic method using a tandem mass spectrometry to determine HMTC in rat plasma. Liquid-liquid extraction with ethyl acetate was used for the clean-up procedure. The analyte was separated on a reversedphase column with mobile phase of distilled water and acetonitrile (2:8, v/v, including 0.1 % formic acid). The ion transition of the precursor to the product ion was principally deprotonated ions [M-H]− at m/z 356.8 → 327.2 for HMTC. This analytical method was successfully applied in pharmacokinetic study of HMTC after intravenous administration in rats.
Abstract
2’-Hydroxy-3’,4’-methylenedioxy-3,4,5-trimethoxychalcone (HMTC) is a newly synthesized chalcone that affects proliferation, cytotoxic potential and apoptosis in human leukemia cells. However, no validated determination method has been described so far for HMTC in biological samples. Thus, we developed a liquid chromatographic method using a tandem mass spectrometry to determine HMTC in rat plasma. Liquid-liquid extraction with ethyl acetate was used for the clean-up procedure. The analyte was separated on a reversedphase column with mobile phase of distilled water and acetonitrile (2:8, v/v, including 0.1 % formic acid). The ion transition of the precursor to the product ion was principally deprotonated ions [M-H]− at m/z 356.8 → 327.2 for HMTC. This analytical method was successfully applied in pharmacokinetic study of HMTC after intravenous administration in rats.
참고문헌 (13)
- G. D. Carlo, , Life Sciences, 65, pp.337~353 (1999)
- F. Herencia, , Bioorganic &Medicinal Chemistry Letters, 8, pp.1169~1174 (1998)
- R. J. Anto, , Cancer Letters, 97, pp.33~37 (1995)
- P. N. Bandeira, , Medicinal Chemistry Research, 28, pp.2037~2049 (2019)
- S. Sale, , Investigational New Drugs, 24, pp.459~464 (2006)
- J. C. J. M. D. S. Menezes, , Journal of Chemical Research, 34, pp.28~29 (2010)
- J. C. J. M. D. S. Menezes, , Rapid Communications in Mass Spectrometry, 27, pp.1303~1310 (2013)
- B. Orlikova, , European Journal of Medicinal Chemistry, 84, pp.173~180 (2014)
- J. Won, , Journal of Food and Drug Analysis, 29, pp.676~683 (2021)
- M. Kim, , Journal of Pharmaceutical and Biomedical Analysis, 137, pp.151~154 (2017)
- N. Sus, , NFS Journal, 10, pp.1~9 (2018)
- W. Kang, , Journal of Pharmaceutical and Biomedical Analysis, 46, pp.587~591 (2008)
- H. Son, , Biomedical Chromatography, 34, pp.e4784~ (2019)